Interestingly, in renal cell carcinoma as well as in head and neck cancers, T-cell infiltration seems to be controlled by the metabolic phenotype of the tumor, as an accelerated tumor glucose metabolism has been associated with a low CD8 effector T-cell infiltration [12]. This evidence concerns the gene CD8A and neoplasm.